Consent to Voluntary Antipsychotic Drug Treatment—Is It Free and Informed?

Refael Yonatan-Leus, Nili Karako-Eyal

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The present research investigates the dynamics of consent in the context of antipsychotic drug therapy, with a particular emphasis on the essential attributes that constitute free and informed consent within medical treatment scenarios. Method: Twenty individuals treated with antipsychotic drugs with consent underwent semistructured interviews. Results: The following major themes were identified: (a) lack or total absence of information regarding the treatment, emphasizing side effects, risks, chances of success, and treatment alternatives. (b) A subjective experience of the lack of free choice that was sometimes also accompanied by the conditioning of psychiatric rehabilitation services or receiving treatment in an open ward by taking antipsychotic medication. Conclusions and Implications for Practice: The research findings may indicate a problem in obtaining informed consent for antipsychotic treatment that should be addressed. The themes highlight the need to examine the interface between rehabilitation services and psychiatric treatment from the legal and ethical perspective of the autonomy of individuals receiving care.

Original languageEnglish
JournalPsychiatric Rehabilitation Journal
Early online date16 Sep 2024
StateE-pub ahead of print - 16 Sep 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024 American Psychological Association

Keywords

  • antipsychotic medications
  • informed consent
  • person-centered decision making
  • psychiatric rehabilitation services

ASJC Scopus subject areas

  • Health Professions (miscellaneous)
  • Rehabilitation
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Consent to Voluntary Antipsychotic Drug Treatment—Is It Free and Informed?'. Together they form a unique fingerprint.

Cite this